SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics (Nasdaq:MBRX), announced today that Dr. Paul Laikind, president and chief executive officer, will present at the 3rd annual BIOCOM Investor Conference on Monday, October 27, 2008 at 3:00 p.m. PDT (6:00 p.m. EDT) at the Hyatt Regency La Jolla in San Diego, California. Dr. Laikind will also present at the Oppenheimer 19th Annual Healthcare Conference on Tuesday, November 4, 2008 at 8:40 a.m. EDT at the Waldorf-Astoria Hotel in New York City. He will also present at the Rodman & Renshaw 10th Annual Healthcare Conference on Tuesday, November 11, 2008 at 9:30 a.m. EDT at The New York Palace in New York City. In addition, Dr. Laikind is scheduled to present at the Piper Jaffray 20th Annual Healthcare Conference on Tuesday, December 2, 2008 at 2:25 p.m. EDT. At all four conferences, he is expected to provide an overview of the Company and its product candidates. The Company’s presentation will be webcast.
